OncoMed Pharmaceuticals Inc Proceeds from Issuance Initial Public Offering
OncoMed Pharmaceuticals Inc reported Proceeds from Issuance Initial Public Offering of $0 for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2016-03-10
- OncoMed Pharmaceuticals Inc proceeds from issuance initial public offering for the quarter ending 2013-12-31 was -$6.00K.
- OncoMed Pharmaceuticals Inc proceeds from issuance initial public offering for fiscal 2013 was $85.15M.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|
| 2014-09-30 | $0.00 10-Q · filed 2014-11-04 | ||
| 2013-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $85.15M 10-K · filed 2016-03-10 | |
| 2013-09-30 | $85.16M 10-Q · filed 2014-11-04 |